Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole)

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Cross Contamination with Other Products
Products
  • Abilify (aripiprazole)
Where it was sold

USA nationwide.

Nationwide

Units affected
N/A
About this recall
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.